Akebia Therapeutics (AKBA) has announced the initiation of an investigator-sponsored study evaluating the use of vadadustat as a potential therapy to prevent and …
Biopharma Akebia Therapeutics (AKBA) skyrocketed 38% in Tuesday’s trading after reporting positive topline data from the global Phase 3 clinical trials of vadadustat. …
Akebia Therapeutics Inc (NASDAQ:AKBA) shares are soaring over 15% as of this writing, after the drug maker announced that it had entered into …
It’s a very rewarding trading day for investors in Akebia Therapeutics Inc (NASDAQ:AKBA), with shares up over 35%, making the stock Wall Street’s …
